Medical Foods Market (Product Type: Pills, Powder, Liquid, and Others; Application: Diabetes, Cancer, Neurological & Psychological Disorders, Metabolic Disorders, Pain Management, Gastrointestinal Disorders, Ophthalmology, and Others; and Distribution Channel: Pharmacies & Drug Stores, Online Channels, Supermarkets & Hypermarkets, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Description

Growth in Demand for Health Foods Boosts Market Growth amidst COVID-19 Pandemic

Since consumers have become conscious about their health amidst the coronavirus (COVID-19) pandemic, companies in the medical foods market are increasing efforts to market their products that assure immunity boost. Since several medical foods are commercially available, it has become easier for manufacturers to promote their products through advertisements. On the other hand, analysts at the opine that China’s import and export of health foods will remain constant in the upcoming months.

The China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE) claims that the demand for medical foods is expected to register a slight growth in 2020. However, insufficiency in raw materials might temporarily affect supply chains in China. Manufacturers are hoping for the COVID-19 pandemic to subside so that global supply chains resume at a normal pace and the medical foods market can grow.

Innovative Protein Substitutes Gain High Demand in Pediatrics Domain

The high prevalence of patients with metabolic disorders in the U.K. have become a growing concern for medical insurance companies due to a rise in insurance claims. Hence, companies in the medical foods market such as leading pharmaceutical company Galen announced the launch of PKU EASY Microtabs for patients with metabolic disorders in February 2020. Such product offerings are bolstering the growth for the medical foods market, which is estimated to reach a value of ~US$ 33.3 Bn by 2030.

The revenue of metabolic disorders is projected for exponential growth in the market for medical foods. Hence, pharmaceutical companies are introducing palatable alternatives to conventional protein substitutes available in the market. These innovative protein substitutes are targeting toward children aged eight and above in order to manage incurable medical conditions such as phenylketonuria. Since high number of babies every year are born with inherited metabolic disorders, companies are increasing their focus to innovate in new protein substitutes.

Companies Target Nutritionally Complete Medical Foods to Prevent Malnutrition in Individuals

Apart from metabolic disorders, companies in the medical foods market such as producer of functional nutrition solutions SternLife, is acquiring proficiency to produce supplementary medical foods for the prevention of malnutrition. The demand for nutritionally complete medical foods is surging in patients suffering from malnutrition. As such, companies in the medical foods market are increasing their production capabilities in bars, powders, and thickening agents. This is evident since the revenue of powdered products is expected to register aggressive growth in the market for medical foods.

Get a glimpse of the in-depth analysis through our Report Brochure

Emerging pharmaceutical companies are collaborating with key market players to help the latter expand their private label clinical nutrition offerings. They are increasing efforts to provide full service assistance by gaining efficacy in the formulation of medical food supplements.

Companies Invest in Innovation Centers Aiming to Introduce Locally Manufactured Products

Leading company Nestlé Health Science is advancing in the domain of nutritional therapy and has announced to invest in a product innovation center in the Taizhou, Jiangsu province of China, to tap into opportunities in the clinical nutrition sector. This explains why the revenue of Asia Pacific is predicted to take an aggressive leap in the medical foods market. As such, innovation centers in China are collaborating with clinical nutrition centers of the U.S. in order to advance in core R&D technologies.

Companies in the medical foods market are innovating to develop localized product offerings that resonate with China’s national standards and consumer needs. They are increasing efforts to comply with regulations involved with Foods for Special Medical Purposes (FSMPs) in China. As such, companies are capitalizing on the growing demand for locally manufactured products, whilst high approval rates for infant and baby formula products are generating incremental opportunities for companies in China.

Post Market Enforcement Tools Help Increase Availability of Quality Products

The medical foods market is slated to progress at a robust CAGR of ~6% during the forecast period. However, stringent regulations regarding medical foods such as prevention of adulteration and compliance with Current Good Manufacturing Practice (CGMP) regulations are posing as a barrier for product approvals. Hence, companies in the medical foods market are increasing efforts to refer published guidelines issued by the FDA (Food and Drug Association) that highlight some of the frequently asked questions of manufacturers. Such FAQs and other guidelines are helping manufacturers to gain better understanding of regulations.

Since the FDA uses tools such as adverse event report monitoring for post market enforcement, consumers can be assured of quality product consumption. Hence, manufacturers are adopting post market enforcement strategies in order to comply with food safety regulations.

Leniency by FDA for Health Claims to Boost Uptake of Products

Microbes and medical foods are gaining commercial importance in the global market landscape. Companies in the medical foods market are increasing their R&D muscle to develop products that meet requirements of the FDA such as products intended for oral intake or administered enterally. They are innovating in products that cater to distinctive nutritional requirements and are based on recognized scientific principles in order to boost uptake of products. Other opportunities such as leniency by the FDA for health claims in products are helping manufacturers to effectively market their products.

Companies are getting involved in careful planning activities to adequately substantiate the health claims in products. On the other hand, manufacturers are increasing their production capabilities to introduce modified carbohydrate and fat enteral formula that are designed for people with chronic obstructive pulmonary disease (COPD), cystic fibrosis, or respiratory failure.

Analysts’ Viewpoint

Companies in the medical foods market are optimistic for revenue growth in the second half of 2020, as COVID-19 is likely to subside in the upcoming months. As such, manufacturers are adopting inorganic strategies such as company acquisitions in order to expand their global reach and maximize their product portfolio.

Health claims are helping companies to increase the commercial uptake of their products. However, the pressure of truthful and non-misleading health claims are emerging as barriers in product launches. Hence, companies should conduct randomized and placebo-controlled clinical trials using the medical foods to gain FDA approval in order to meet substantiation requirements of the FDA.

Medical Foods Market: Overview

The global medical foods market for the historical period 2018–2019 and forecast period from 2020 to 2030, high demand for medical food products is projected to be a major driver of the global medical foods market during the forecast period

The global medical foods market was valued at US$ 18 Bn in 2019 and is anticipated to expand at a CAGR of ~6% from 2020 to 2030

The report analyzes the current and future scenario of the global medical foods market

The global medical foods market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global medical foods market with respect to the segments based on product type, application, distribution channel, and region.

A detailed qualitative analysis of drivers, restraints, and opportunities of the global medical foods market has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles, along with business overview to understand the competition landscape of the global medical foods market.

This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global medical foods market

Medical Foods Market: Key Drivers

Providing adequate nutritional support is a central component for the care of prolonged or chronically ill patients. Hence, demand for clinical nutrition is constantly increasing among patients with chronic disorders such as gastrointestinal disorders, short bowel syndrome, ischemic bowel disease, Crohn’s disease, and renal failure. Rise in prevalence of these diseases drives the demand for medical foods. 

Statistics from various government organizations indicate that incidence of chronic diseases such as gastrointestinal disorders and chronic kidney diseases is increasing rapidly

For instance, incidence of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis is rising. This drives the demand for medical food products across the globe. As per the statistics provided by the Crohn’s & Colitis Foundation of America, around 1.6 million people in the U.S. have Crohn's disease or ulcerative colitis. The organization also stated that more than 70,000 new cases are diagnosed with Crohn's disease and ulcerative colitis in the U.S. each year.

Moreover, the National Kidney Foundation stated that around 10% of the world’s population is affected by chronic kidney disease each year. The Centers for Disease Control and Prevention also noted that more than 20 million people in the U.S. have chronic kidney disease each year.

Hence, factors and statistics mentioned above indicate that increase in incidence of various chronic disorders is likely to fuel the growth of the global medical foods market

Malnutrition is when the body is not able to get enough nutrients, which may be caused due to poor diet, chronic diseases, or digestive conditions. The effects of malnutrition on morbidity result chiefly from delayed wound healing, decreased functional status, impaired immune function, and convalescence from illness.

Oncology patient groups are at high risk of malnutrition. Multiple studies have found that malnutrition is a considerable financial drain on healthcare systems, as it affects 70% of hospitalized patients across the world. The high cost burden is caused due to frequent hospital visits, extended hospital stays, and a greater risk of complications.

Parenteral nutrition plays a significant role in cases where malnourished patients need to be administered nutrition; however, enteral nutrition is inadequate to meet their body nutritional requirements

Rise in prevalence of malnutrition coupled with an increased use of nutrition for cancer treatment is expected to propel the global market

Medical Foods Market: Key Segments

In terms of product type, the global medical foods market has been classified into pills, powder, liquids, and others

Based on application, the global medical foods market has been categorized into diabetes, cancer, neurological & psychological disorders, metabolic disorder, pain management, gastrointestinal disorders, ophthalmology, and others

Based on distribution channel, the global medical foods market has been categorized into pharmacies & drug stores, online channels, supermarkets & hypermarkets,  and others

The market size and forecast for each of the segments have been provided in terms of US$ Mn from 2018 to 2030, along with their respective CAGRs for the forecast period from 2020 to 2030, considering 2018 as the base year

Medical Foods Market: Regional Outlook

Geographically, the global medical foods market has been segmented into four major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of the Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)

The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2018 to 2030, along with their respective CAGRs for the forecast period from 2020 to 2030, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the following major players in the global medical foods market based on various attributes such as company overview, financial overview, product types, business strategies, and recent developments. These include 

  • Nestlé S.A.
  • Danone S.A.
  • Abbott Laboratories
  • Fresenius SE & Co. KGaA,
  • Targeted Medical Pharma, Inc.
  • Primus Pharmaceuticals, Inc.
  • Reckitt Benckiser Group plc
  • Meiji Holdings and Co., Ltd.
  • Cerecin Inc.,
  • Metagenics, Inc.

Key Questions Answered in Medical Foods Market Report

  • What will be the sales/revenue generated by different medical foods product types across all the regions during the forecast period?
  • What are the major drivers, restraints, and opportunities of the global medical foods market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2027 and which product type segment will expand at the fastest CAGR during the forecast period?

Medical Foods Market – Segmentation

Product Type

  • Pills
  • Powder
  • Liquid
  • Others

Application

  • Diabetes
  • Cancer
  • Neurological & Psychological Disorders
  • Metabolic Disorders
  • Pain Management
  • Gastrointestinal Disorders
  • Ophthalmology
  • Others

Distribution Channel

  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Online Channels
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface 

    1.1. Report Scope and Market Segmentation 

    1.2. Research Highlights

2. Assumptions and Research Methodology 

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Medical Foods Market: Market Snapshot

4. Market Overview

    4.1. Global Medical Foods Market: Type Overview 

    4.2. Global Medical Foods Market: Key Industry Developments

    4.3. Market Dynamics

    4.4. Drivers and Restraints Snapshot Analysis

    4.5. Drivers

    4.6. Restraints

    4.7. Opportunities

    4.8. Global Medical Foods Market Revenue Projections (US$ Mn), 2018–2030

5. Key Insights

    5.1. Key Mergers & Acquisitions 

    5.2. Regulatory Scenario Assessment

    5.3. Disease Prevalence & Incidence Rate globally with Key Countries

    5.4. Top Players Operating in the Market

6. Global Medical Foods Market Analysis, by Product Type

    6.1. Introduction

    6.2. Global Medical Foods Market Value and Forecast, by Product Type

        6.2.1. Pills

        6.2.2. Powder

        6.2.3. Liquid

        6.2.4. Others

    6.3. Global Medical Foods Market Analysis, by Product Type

    6.4. Global Medical Foods Market Attractiveness Analysis, by Product Type

7. Global Medical Foods Market Analysis, by Application

    7.1. Introduction

    7.2. Global Medical Foods Market Value and Forecast, by Application

        7.2.1. Diabetes

        7.2.2. Cancer

        7.2.3. Neurological and Psychological Disorders

        7.2.4. Metabolic Disorder

        7.2.5. Pain Management

        7.2.6. Gastrointestinal Disorders

        7.2.7. Ophthalmology

        7.2.8. Others

    7.3. Global Medical Foods Market Analysis, by Application

    7.4. Global Medical Foods Market Attractiveness Analysis, by Application

8. Global Medical Foods Market Analysis, by Distribution Channel

    8.1. Introduction

    8.2. Global Medical Foods Market Value and Forecast, by Distribution Channel

        8.2.1. Pharmacies & Drug Stores

        8.2.2. Supermarkets & Hypermarkets

        8.2.3. Online Channels

        8.2.4. Others

    8.3. Global Medical Foods Market Analysis, by Distribution Channel

    8.4. Global Medical Foods Market Attractiveness Analysis, by Distribution Channel

9. Global Medical Foods Market Analysis, by Region

    9.1. Global Medical Foods Market Value and Forecast, by Region, 2018–20230 

        9.1.1. North America

        9.1.2. Europe

        9.1.3. Latin America

        9.1.4. Middle East & Africa

    9.2. Global Medical Foods Market Analysis, by Region

    9.3. Global Medical Foods Market Attractiveness Analysis, by Region

10. North America Medical Foods Market Analysis

    10.1. North America Medical Foods Market 

    10.2. North America Medical Foods Market Overview

    10.3. North America Medical Foods Market Value and Forecast, by Product Type

        10.3.1. Pills

        10.3.2. Powder

        10.3.3. Liquid

        10.3.4. Others

    10.4. North America Medical Foods Market Value and Forecast, by Application

        10.4.1. Diabetes

        10.4.2. Cancer

        10.4.3. Neurological and Psychological Disorders

        10.4.4. Metabolic Disorder

        10.4.5. Pain Management

        10.4.6. Gastrointestinal Disorders

        10.4.7. Ophthalmology

        10.4.8. Others

    10.5. North America Medical Foods Market Value and Forecast, by Distribution Channel

        10.5.1. Pharmacies & Drug Stores

        10.5.2. Supermarkets & Hypermarkets

        10.5.3. Online Channels

        10.5.4. Others

    10.6. North America Medical Foods Market Forecast, by Country

        10.6.1. U.S.

        10.6.2. Canada

    10.7. North America Medical Foods Market Attractiveness Analysis 

        10.7.1. By Product Type

        10.7.2. By Application 

        10.7.3. By Distribution Channel

        10.7.4. By Country

11. Europe Medical Foods Market Analysis

    11.1. Europe Medical Foods Market 

    11.2. Europe Medical Foods Market Overview

    11.3. Europe Medical Foods Market Value and Forecast, by Product Type

        11.3.1. Pills

        11.3.2. Powder

        11.3.3. Liquid

        11.3.4. Others

    11.4. Europe Medical Foods Market Value and Forecast, by Application

        11.4.1. Diabetes

        11.4.2. Cancer

        11.4.3. Neurological and Psychological Disorders

        11.4.4. Metabolic Disorder

        11.4.5. Pain Management

        11.4.6. Gastrointestinal Disorders

        11.4.7. Ophthalmology

        11.4.8. Others

    11.5. Europe Medical Foods Market Value and Forecast, by Distribution Channel

        11.5.1. Pharmacies & Drug Stores

        11.5.2. Supermarkets & Hypermarkets

        11.5.3. Online Channels

        11.5.4. Others

    11.6. Europe Medical Foods Market Forecast, by Country/Sub-region

        11.6.1. U.K.

        11.6.2. France

        11.6.3. Germany

        11.6.4. Spain

        11.6.5. Italy

        11.6.6. Rest of Europe

    11.7. Europe Medical Foods Market Attractiveness Analysis 

        11.7.1. By Product Type

        11.7.2. By Application

        11.7.3. By Route of Administration

        11.7.4. By Distribution Channel

        11.7.5. By Country/Sub-region

12. Asia Pacific Medical Foods Market Analysis

    12.1. Asia Pacific Medical Foods Market 

    12.2. Asia Pacific Medical Foods Market Overview

    12.3. Asia Pacific Medical Foods Market Value and Forecast, by Product Type

        12.3.1. Pills

        12.3.2. Powder

        12.3.3. Liquid

        12.3.4. Others

    12.4. Asia Pacific Medical Foods Market Value and Forecast, by Application

        12.4.1. Diabetes

        12.4.2. Cancer

        12.4.3. Neurological and Psychological Disorders

        12.4.4. Metabolic Disorder

        12.4.5. Pain Management

        12.4.6. Gastrointestinal Disorders

        12.4.7. Ophthalmology

        12.4.8. Others

    12.5. Asia Pacific Medical Foods Market Value and Forecast, by Distribution Channel

        12.5.1. Pharmacies & Drug Stores

        12.5.2. Supermarkets & Hypermarkets

        12.5.3. Online Channels

        12.5.4. Others

    12.6. Asia Pacific Medical Foods Market Forecast, by Country/Sub-region

        12.6.1. China

        12.6.2. India

        12.6.3. Japan

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Asia Pacific Medical Foods Market Attractiveness Analysis 

        12.7.1. By Product Type

        12.7.2. By Application

        12.7.3. By Distribution Channel

        12.7.4. By Country/Sub-region

13. Latin America Medical Foods Market Analysis

    13.1. Latin America Medical Foods Market 

    13.2. Latin America Medical Foods Market Overview

    13.3. Latin America Medical Foods Market Value and Forecast, by Product Type

        13.3.1. Pills

        13.3.2. Powder

        13.3.3. Liquid

        13.3.4. Others

    13.4. Latin America Medical Foods Market Value and Forecast, by Application

        13.4.1. Diabetes

        13.4.2. Cancer

        13.4.3. Neurological and Psychological Disorders

        13.4.4. Metabolic Disorder

        13.4.5. Pain Management

        13.4.6. Gastrointestinal Disorders

        13.4.7. Ophthalmology

        13.4.8. Others

    13.5. Latin America Medical Foods Market Value and Forecast, by Distribution Channel

        13.5.1. Pharmacies & Drug Stores

        13.5.2. Supermarkets & Hypermarkets

        13.5.3. Online Channels

        13.5.4. Others

    13.6. Latin America Medical Foods Market Forecast, by Country/Sub-region

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Latin America Medical Foods Market Attractiveness Analysis 

        13.7.1. By Product Type

        13.7.2. By Application

        13.7.3. By Distribution Channel

        13.7.4. By Country/Sub-region

14. Middle East & Africa Medical Foods Market Analysis

    14.1. Middle East & Africa Medical Foods Market 

    14.2. Middle East & Africa Medical Foods Market Overview

    14.3. Middle East & Africa Medical Foods Market Value and Forecast, by Product Type

        14.3.1. Pills

        14.3.2. Powder

        14.3.3. Liquid

        14.3.4. Others

    14.4. Middle East & Africa Medical Foods Market Value and Forecast, by Application

        14.4.1. Diabetes

        14.4.2. Cancer

        14.4.3. Neurological and Psychological Disorders

        14.4.4. Metabolic Disorder

        14.4.5. Pain Management

        14.4.6. Gastrointestinal Disorders

        14.4.7. Ophthalmology

        14.4.8. Others

    14.5. Middle East & Africa Medical Foods Market Value and Forecast, by Distribution Channel

        14.5.1. Pharmacies & Drug Stores

        14.5.2. Supermarkets & Hypermarkets

        14.5.3. Online Channels

        14.5.4. Others

    14.6. Middle East & Africa Medical Foods Market Forecast, by Country/Sub-region

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Middle East & Africa Medical Foods Market Attractiveness Analysis 

        14.7.1. By Product Type

        14.7.2. By Application

        14.7.3. By Distribution Channel

        14.7.4. By Country/Sub-region

15. Competitive Landscape 

    15.1. Company Profiles

        15.1.1. Nestlé S.A.

            15.1.1.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.1.2. Financials

            15.1.1.3. Recent Developments

            15.1.1.4. Strategy

        15.1.2. Danone S.A. 

            15.1.2.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.2.2. Financials

            15.1.2.3. Recent Developments

            15.1.2.4. Strategy

        15.1.3. Abbott Laboratories

            15.1.3.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.3.2. Financials

            15.1.3.3. Recent Developments

            15.1.3.4. Strategy

        15.1.4. Fresenius SE & Co. KGaA

            15.1.4.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.4.2. Financials

            15.1.4.3. Recent Developments

            15.1.4.4. Strategy

        15.1.5. Targeted Medical Pharma, Inc.

            15.1.5.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.5.2. Financials

            15.1.5.3. Recent Developments

            15.1.5.4. Strategy

        15.1.6. Primus Pharmaceuticals, Inc. 

            15.1.6.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.6.2. Financials

            15.1.6.3. Recent Developments

            15.1.6.4. Strategy

        15.1.7. Reckitt Benckiser Group Plc

            15.1.7.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.7.2. Financials

            15.1.7.3. Recent Developments

            15.1.7.4. Strategy

        15.1.8. Meiji Holdings and Co., Ltd. 

            15.1.8.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.8.2. Financials

            15.1.8.3. Recent Developments

            15.1.8.4. Strategy

        15.1.9. Cerecin Inc. 

            15.1.9.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.9.2. Financials

            15.1.9.3. Recent Developments

            15.1.9.4. Strategy

        15.1.10. Metagenics, Inc.

            15.1.10.1. Overview (HQ, Employee Strength, Business Segments)

            15.1.10.2. Financials

            15.1.10.3. Recent Developments

            15.1.10.4. Strategy

Choose License Type

Checkout Inquiry Sample